ACELYRIN - Multiplikator nilai perusahaan marang pendapatan SLRN

acelyrin.com (SLRN) - logo korporat

Acelyrin, Inc. (SLRN) possesses significant pricing power due to innovative proteins that effectively block interleukin-17A. The immediate growth driver will be the results of final trials for anti-inflammatory molecules. After examining the firm's EV/Sales multiple valuation on GURU.Markets, we find that determines the latest valuation metric. Supply stability is guaranteed by strict adherence to temperature controls during the transportation of immunological drugs to clinics.

ACELYRIN (SLRN) - Nilai perusahaan marang pendapatan saka 04.07.2022 nganti 20.11.2026

ACELYRIN Inc. - rincian analitis lan metrik utama (SLRN)

- nilai pasar lan prakiraan target analis:
Analisis wiwitan perusahaan:ACELYRIN, SLRN
Sampel barang ACELYRIN, Inc.

This indicator measures the ratio of total enterprise value to annual sales, excluding the impact of debt to identify the actual market overvaluation of assets. By analyzing the enterprise value-to-revenue level on GURU.Markets, an investor can assess whether the capitalization of Acelyrin, Inc. (SLRN) is justified, given the colossal R&D expenditures and prolonged clinical trials of immunological drugs prior to their commercialization.

Pesaing langsung

HLN: Rasio nilai perusahaan marang pendapatan|Kenvue Corp (KVUE) - Rasio nilai perusahaan marang pendapatan|Verona Pharma PLC - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Jyong Biotech Ltd|Multiplikator EV/Sales Ligand Corp|Multiplikator EV/Sales AMRX|Rasio total nilai perusahaan marang pendapatan Perrigo Company plc|Multiplikator EV/Sales ALVO (Alvotech Biopharmaceuticals)|LQDA: Rasio nilai perusahaan marang pendapatan|Galapagos N.V. - Multiplikator EV/Sales|ANIP - Multiplikator EV/Sales|MNKD: Multiplikator EV/Sales|amphastar.com (AMPH) - Multiplikator EV/Sales|PCRX (Pacira Pharmaceuticals) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan ARS Pharmaceuticals, Inc. (SPRY)|Multiplikator EV/Sales TBPH|AQST (Aquestive Therapeutics) - Nilai bisnis marang pendapatan|scPharmaceuticals, Inc. - Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan TECX|tonixpharma.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan BioHarvest|Nilai perusahaan marang pendapatan EXOZ|Nilai perusahaan marang pendapatan Oramed Pharmaceuticals (ORMP)|Nilai perusahaan marang pendapatan ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales ABVC (ABVC BioPharma Inc)|CPIX - Nilai perusahaan marang pendapatan|Quantum BioPharma Corp - Multiplikator EV/Sales|FGEN (fibrogen.com) - Rasio nilai perusahaan marang pendapatan|TELO (Telomir Pharmaceuticals) - Nilai perusahaan marang pendapatan|Rani Therapeutics Holdings - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan SNYR|Multiplikator nilai perusahaan marang pendapatan rallybio.com RLYB|Multiplikator EV/Sales LEXX|PULM (Pulmatrix, Inc.) - Nilai bisnis marang pendapatan|Pheton Holdings - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales Aptorum Group Limited APM|LYRA: Nilai perusahaan marang pendapatan|IBO: Rasio nilai perusahaan marang pendapatan|TNFA: Multiplikator EV/Sales|YCBD: Koefisien nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan PainReform Ltd|CYTO (altamiratherapeutics.com) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIPO|OPTN - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan pieris.com PIRS|Nilai bisnis marang pendapatan PROC|PTPI - Rasio nilai perusahaan marang pendapatan|Qilian International Holding (QLI) - Nilai perusahaan marang pendapatan|TFF Pharmaceuticals, Inc (TFFP) - Rasio nilai perusahaan marang pendapatan